ICD-10-CM Billable Code

M11.241

Other chondrocalcinosis, right hand

Clinical Classification Guidelines

Medical Intelligence & Overview

Chondrocalcinosis, also known as pseudogout, is a joint condition characterized by the abnormal deposit of calcium pyrophosphate dihydrate (CPPD) crystals in the cartilage of joints. When these deposits occur specifically in the right hand, it is classified under the ICD-10 code M11.241. This condition can lead to joint pain, swelling, and stiffness, impacting daily activities and overall quality of life. While it can affect any joint, the hands are a common site, especially in older adults. Understanding the causes, symptoms, and available management options can help individuals better navigate this condition.

Causes & Symptoms

Clinical Causes: Aging: The risk of developing chondrocalcinosis increases with age, as cartilage calcification becomes more common over time. Genetic factors: A family history of the condition can predispose individuals to develop calcium deposit issues. Joint injury or trauma: Previous injuries to the hand or joints may contribute to abnormal crystal deposits. Metabolic disorders: Conditions such as hyperparathyroidism, hemochromatosis, or hypophosphatasia are associated with increased risk. Other joint diseases: Osteoarthritis and other degenerative joint diseases can coexist with chondrocalcinosis.

Key Symptoms: Joint pain that worsens with activity or movement Swelling in the affected joints, often the knuckles or finger joints of the right hand Stiffness, particularly after periods of inactivity or in the morning Tenderness around the affected joints Possible warmth or redness of the skin over the joint Limited range of motion in the fingers or hand Recurrent episodes of joint inflammation, sometimes mimicking gout

Diagnostic & Treatment

Diagnosis Path: Diagnosing chondrocalcinosis involves a combination of medical history, physical examination, and imaging studies. Key diagnostic steps include: - **X-rays**: Imaging reveals calcification deposits within the cartilage, characteristic of chondrocalcinosis. - **Joint aspiration**: Removing joint fluid to examine under a microscope can identify CPPD crystals. - **Laboratory tests**: Blood tests may help assess underlying metabolic conditions or rule out other causes of joint inflammation. It's essential for healthcare providers to differentiate chondrocalcinosis from other joint diseases such as gout or osteoarthritis, as management strategies may differ.

Treatment Protocols: While there is no cure for chondrocalcinosis, various treatments aim to manage symptoms and prevent joint damage: - **Medications**: - Nonsteroidal anti-inflammatory drugs (NSAIDs) for pain and inflammation relief. - Colchicine, particularly during flare-ups, to reduce the frequency of attacks. - Corticosteroid injections directly into the affected joint for severe inflammation. - **Lifestyle modifications**: - Resting the affected hand during acute episodes. - Applying ice packs to reduce swelling and pain. - Engaging in gentle hand exercises to maintain joint flexibility. - **Managing underlying conditions**: - Treating metabolic disorders like hyperparathyroidism or hemochromatosis when present. - **Surgical options**: - In rare cases, surgical removal of calcium deposits or joint replacement may be considered if joint damage is extensive. Regular follow-up with healthcare providers is important to monitor disease progression and adjust treatment plans accordingly.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is M11.241 a billable ICD-10 code?
Yes, M11.241 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report M11.241?
Clinical documentation must specify the nature of Other chondrocalcinosis, right hand and any associated comorbidities for accurate reporting.

Cite this Clinical Reference